E Chiocca

29PUBLICATIONS

243CO-AUTHORS

Molecular targetsPredictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)Cancer therapy (excl. chemotherapy and radiation therapy)Genome structure and regulation

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (29)

Sort by Publication Date:

|Jun 17, 2026

IDH1-R132H enhances oncolytic HSV-1 therapy by facilitating viral entry and immune activation in glioma.

|Jun 12, 2026

Publisher Correction: Tumor transcriptional state predicts survival in immune-checkpoint-blockade-treated glioblastoma.

|Jun 03, 2026

Tumor transcriptional state predicts survival in immune-checkpoint-blockade-treated glioblastoma.

|May 22, 2026

Treatment Effect Reanalysis of the Randomized Individual Screening Trial of Innovative Glioblastoma Therapy in Newly Diagnosed Glioblastoma With External Control Data.

|Apr 24, 2026

Oncolytic viruses and cytokine-based gene therapies reprogram the tumor microenvironment.

|Mar 24, 2026

HNRNPH1 drives glioblastoma progression by regulating the splicing of cell cycle genes.

Genaro R Villa, Paolo Alimonti, Joseph S Toker

Pageof 5

Frequent Collaborators

12 joint publications

David A Reardon

12 joint publications

Keith Ligon

Joshua D Bernstock

Patrick Y Wen

Pierpaolo Peruzzi

Wenya Linda Bi

Genaro R Villa

Laxmi Parida

Gregory K Friedman

Gad Getz

Frequent Collaborators

12 joint publications

David A Reardon

12 joint publications

Keith Ligon

8 joint publications

Joshua D Bernstock

7 joint publications

Patrick Y Wen